beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
about
Cytokines as new treatment targets in chronic heart failureThe enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.Are all beta-blockers the same for chronic heart failure?Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice.The severe cardiorenal syndrome: 'Guyton revisited'.Caffeic acid protects rat heart mitochondria against isoproterenol-induced oxidative damage.Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy.Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications.Initiation and use of beta-blockers in class IV heart failure.Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Systemic inflammation in heart failure--the whys and wherefores.Role of inflammation in the progression of heart failure.Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in ratsPleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.The immune system and cardiac repair.Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats.Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol.Biomarkers of inflammation in heart failure.Morphological and molecular changes of the myocardium after left ventricular mechanical supportBrain renin-angiotensin-aldosterone system and ventricular remodeling after myocardial infarct: a review.Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia.Beta-blockers and risk of all-cause mortality in non-cardiac surgery.Multiple cytokine biomarkers in heart failure.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?Dilated cardiomyopathy update: infectious-immune theory revisited.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure.Pro-inflammatory cytokines mediate GPCR dysfunction.Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction.Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.Perioperative cardioprotection.Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism.Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension.Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.
P2860
Q24799394-4394798F-8380-4A03-A5E2-E06E8CA24F8EQ30320708-14ED1FDA-7B83-465A-9062-53E175DA4C84Q31934918-3EBE51F8-76C2-4B51-ABAA-F7F104351949Q34188766-1498C739-88FB-41F7-8F4C-BC96D3E66CF2Q34379161-954DE121-03D5-4A71-A369-EFB9F80E6D98Q34505707-5320EB34-A445-4369-98CB-1BCC37FFF424Q35000998-A371B819-EBC9-4966-BE79-697873611216Q36072891-DDD2B0F6-97EE-4743-A731-BC0BFC2561A7Q36198484-C2FCC149-04A1-4036-82F0-18DF3176C937Q36203056-3D3EF317-9319-4F02-97B0-7E48AC7FB889Q36203101-4C47C048-818A-4175-9FB8-8F26D8ACC6E7Q36337179-897ACA0F-0752-4251-90CF-1FDDD2739CE2Q36526913-03BE4EDF-137A-43F2-B0A1-578D9A4A35BCQ36806972-812BA485-03B8-4F0D-994E-C296C0DD6C1BQ36955252-BEE6E170-68A4-400A-BF6F-EC18C6B3C405Q37033164-5A6E5E1C-3153-4C39-987D-F63A2658D9BEQ37078949-124C1CD0-5697-4B9C-8A9C-80B154FB6A48Q37096652-2392FBD8-87E4-4B68-99C9-504F1F5A6241Q37400315-1E5C66C6-2D72-4655-8332-D05C66EFE08EQ37402717-1F0ADFA6-9F96-4B9F-9C4C-7D0D0F6C1075Q37442709-6834A937-8848-4F36-977C-DFF8E48AFF94Q37638247-90DF9D00-765A-42D9-B401-659B3128C946Q37661383-97CC5AA6-8E29-45C6-B03C-3EFFC27EB8AFQ37696435-AE411C38-8862-460C-A860-8C1BD47E08D7Q37702033-2FE91143-0A3E-4A56-BB6C-24425A17565BQ37705430-775B2DEF-5184-4817-929E-BC75AF061AB9Q37891878-F8163F4E-8824-47FD-A7AE-56900E8FBD22Q38046798-8E421978-7DC0-4FFF-BE9E-7B13F4D14C63Q38124734-1F8C684E-1E11-483C-A0B5-154947C88FA3Q38183314-4FFE7692-499E-43C3-961C-CCA4566A01D5Q38695069-224717E6-1D53-477E-AB32-342CBFF26653Q39070066-2FDC60EF-88E1-467A-BC8A-ED9C085FFD3DQ39407942-CC459CFA-2162-431E-861C-F7941695A2E4Q39662869-DFDA10C5-E1D9-4C58-989C-7F25F4541C94Q39992588-5DE6D54A-9BE2-4266-BC25-DD62A47BC633Q41498749-820CE32A-902C-4515-B9CB-E67426054108Q41642167-24772B2B-C9FE-4C4C-9018-90D935288F2BQ41787966-31069A5D-1D35-460A-8775-5D6E1B20C5FAQ41789551-70D2F1EE-F30B-4598-88CF-9DB214D8880CQ41807919-8FE9142D-9EF7-4212-9C3A-24B998B0EDD8
P2860
beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@ast
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@en
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@nl
type
label
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@ast
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@en
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@nl
prefLabel
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@ast
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@en
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@nl
P2093
P3181
P1433
P1476
beta-adrenergic blockade in de ...... , nitric oxide, and remodeling
@en
P2093
B Chandrasekar
D R Murray
G L Freeman
S D Prabhu
P304
P3181
P356
10.1161/01.CIR.101.17.2103
P407
P577
2000-05-02T00:00:00Z